PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular Biology, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.\', \'Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.\', \'Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.\', \'Faculty of Biology and Psychology, University of Göttingen, 37073 Göttingen, Germany.\', \'Department of Psychiatry and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Schwabachanlage 6, 91054 Erlangen, Germany.\', \'Department of Surgery, University of Cincinnati Medical School, 231 Albert Sabin Way, ML0558, Cincinnati, OH 45267, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1016/j.xpro.2021.100356
?:doi
?:hasPublicationType
?:journal
  • STAR protocols
is ?:pmid of
?:pmid
?:pmid
  • 33558862
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33558862>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33558862>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all